Insights into Company Bills & Payments

Indo Count Industries ↗

📍 Kolhapur, PN, India Active NSE ICIL CIN L72200PN1988PLC068972 Apparel, Textiles & Footwear
Search companies

Key Metrics of Indo Count Industries

Revenue₹3,098 Cr▼ 17.9% YoYFY 2025-26
EBITDA₹379 Cr▼ 26.2% YoY
Net profit₹145 Cr▼ 39.0% YoY
Net worth₹2,316 Cr▲ 3.6% YoY
Competitors10identified

About Indo Count Industries

Sectors

Apparel, Textiles & FootwearTextiles, Cotton & Yarn

Company details

Website
indocount.com
Registered office
Office No. 1, Plot No. 266, Village Alte, Kumbhoj Road, Taluka Hatkanangale,, Kolhapur, In-mh, 416109
Listed
NSE: ICIL · ₹449.30

Operational Areas of Indo Count Industries

Apparel, Textiles & Footwear›Textiles, Cotton & Yarn

Company summary

Entity details

CINL72200PN1988PLC068972
LEI code335800K2IZ3N44GS9379
State codePN
PIN code416109
Current legal nameINDO COUNT INDUSTRIES
Classification—
Listing statusListed (NSE: ICIL)
Registration no.068972
Company age—
PAN—
CountryIndia
CityKolhapur
StatePN
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code72200
Description of main activityComputer and related activities (software, IT services)
Description of business activityComputer and related activities (software, IT services)
SectorApparel, Textiles & Footwear · Textiles, Cotton & Yarn

Share price · NSE: ICIL

ICIL on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

ICRA · 12 Oct 2026 ICRA AA- Stable outlook · Short term A1+ · Reaffirmed
CARE · 05 Oct 2026 CARE AA- Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▲ 1 notchsince Sep 2019
Rating actions110 up · 0 down
Liquidity (ICRA)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
12 Oct 2026ICRAReaffirmed AA-A1+Stable₹1,763 Cr View
05 Oct 2026CAREReaffirmed AA-A1+Stable₹1,754 Cr View
05 Sep 2025CAREReaffirmed AA-A1+Stable₹1,756 Cr View
25 Sep 2024CAREReaffirmed AA-A1+Positive₹1,642 Cr View
30 Nov 2023CAREReaffirmed AA-A1+Stable₹1,676 Cr View
22 Dec 2022CAREReaffirmed AA-A1+Stable₹1,756 Cr View
05 Dec 2022CAREReaffirmed (from A+) AA-A1+Stable₹2,297 Cr View
15 Dec 2021CAREOther ———— View
07 Sep 2021CARERevised A+A1+Positive₹1,148 Cr View
23 Sep 2020CAREReaffirmed A+A1Stable₹1,610 Cr View
10 Sep 2019CARERevised (from AA) A+A1Stable₹826 Cr View

Credit strengths (ICRA, Oct 2026)

+ Experience of promoters and established presence of the company in the home textiles industry

The company continues to benefit from over three decades of experience of its promoters in the textile business.

+ Long-term relationships with reputed clientele, leading to repeat orders

ICIL’s major customers include global big-box retailers in the US, Canada and Europe such as Walmart, Costco, Revman, Kohl’s, JC Penney among others.

+ Healthy financial profile characterised by a conservative capital structure and comfortable debt protection metrics

ICIL’s capital structure remains comfortable, with a healthy net worth base (Rs. 2,355 crore as of March 31, 2026), even after the debt-funded acquisitions and sizeable capex undertaken by the company in recent years.

+ Enhanced capacity and investment in brands in US operations, resulting in asset and product line diversification

The company has been focussing on strengthening its footprint in the US over the past few years.

Credit challenges

− Significant geographical and customer concentration of revenue

ICIL’s sales exhibit a high degree of geographical and customer concentration, with the US accounting for around 70% of its exports of bed linens from India and the top two customers accounting for 30-35% of its revenues, at present.

− High working capital intensity of operations due to sizeable stocking requirements, albeit order-backed inventory

ICIL’s operations remain working capital intensive due to the need for large stocking of raw materials owing to seasonal availabilit y of cotton.

Could lead to an upgrade

ICRA may upgrade the long-term rating of ICIL if the company is able to demonstrate a substantial and sustained growth in revenues along with increasing scale of US operations and an improvement in the overall profitability. Besides, maintaining a healthy capital structure, strengthening its coverage metrics and improving the working capital cycle, thereby positively impacting its

Could lead to a downgrade

ICRA may downgrade ICIL’s ratings in case of continuing pressure on the company’s revenues and/or profitability, thereby weakening debt protection metrics and

Agency-reported financials (ICRA, 12 Oct 2026)

MetricFY2025FY2026FY2025FY2026Q1 FY2027Q1 FY2026
Operating income₹3,774 Cr₹3,101 Cr₹4,151 Cr₹4,141 Cr₹1,207 Cr₹959 Cr
PAT₹237 Cr₹141 Cr₹250 Cr₹123 Cr₹63.20 Cr₹39.00 Cr
OPBDIT/OI13.0%11.2%13.5%10.6%11.9%11.6%
PAT/OI6.3%4.5%6.0%3.0%5.2%4.1%
Total outside liabilities/Tangible net worth (times)0.70×0.60×0.90×0.90×——
Total debt/OPBDIT (times)2.20×2.40×2.60×3.10×——
Interest coverage (times)4.60×3.70×4.60×3.20×4.50×3.60×
Revenue growth (YoY)—−17.8%33.9%−0.2%——
EBITDA (margin × income)₹491 Cr₹347 Cr₹560 Cr₹439 Cr₹144 Cr₹111 Cr
Implied total debt (debt/EBITDA × EBITDA)₹1,079 Cr₹834 Cr₹1,457 Cr₹1,361 Cr——
Implied interest cost (EBITDA ÷ coverage)₹107 Cr₹93.88 Cr₹122 Cr₹137 Cr₹31.92 Cr₹30.89 Cr

Borrowings & rated debt

Rated borrowing limits (latest)₹1,763 Cr
Peak rated limits₹2,297 CrDec 2022 · CARE
Limits raised1 time0 new facilities rated
Average remaining tenor2.7 years
Next maturity31 Mar 2028₹14.2 Cr

Rated limits over time

Facility mix

Maturity ladder

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term Fund based – Term LoanTerm loans₹119 Cr₹117 Cr−1.4% AA- (Stable)ReaffirmedICRA
Long-term Fund-based – Working Capital , Facilities Short-term Non-Fund-based – WorkingNon-fund based limits₹1,500 Cr₹1,500 Cr0.0% AA- (Stable)ReaffirmedICRA
Capital FacilitiesOther₹137 Cr₹137 Cr0.0% A1+ReaffirmedICRA
Long-term Short-term – Unallocated , LimitsWorking capital & bank lines₹7.57 Cr₹9.22 Cr21.8% AA- / A1+ (Stable)ReaffirmedICRA

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
—Term Loan I FY FYTerm loans— 31 Mar 202231 Mar 2028 ₹14.2 CrAA- Outstanding
—Term Loan II FY FYTerm loans— 31 Mar 202331 Mar 2029 ₹54.9 CrAA- Outstanding
—Term Loan III FY FYTerm loans— 31 Mar 202631 Mar 2030 ₹48.0 CrAA- Outstanding

CARE ratings on record (checked 26 Oct 2026)

InstrumentAmountRating
BG/LC₹137 CrCARE A1+
Non Convertible Debentures—Withdrawn
Short Term₹1,500 CrCARE A1+
Term Loan₹117 CrCARE AA-; Stable

Lenders

Fund-basedShort TermAxis Bank Ltd.
Fund-basedShort TermBank of Baroda
Fund-basedShort TermCiti Bank
Fund-basedShort TermHDFC Bank Ltd.
Fund-basedShort TermHSBC Ltd.
Fund-basedShort TermJ.P. Morgan Chase Bank N.A.
Fund-basedShort TermUnion Bank of India
Fund-based - LTTerm LoanBank of Baroda
Fund-based - LTTerm LoanExport Import Bank of India
Fund-based - LTTerm LoanHDFC Bank Ltd.
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCBank of Baroda
Non-fund-based - STBG/LCUnion Bank of India

Credit assessment · Cotton textile

Rating Methodology – Cotton Textile (Sep 2026) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequateAgency: Adequate
DirectionRating watch – DevelopingAgency outlook: Stable
ICRA rating · Oct 2026AA-1 notch above indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)57%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 57% (At risk of downgrade) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹1,763 Cr
Not yet allocated₹9.22 Cr
Extra debt within 3.5× EBITDA—
Interest coverage3.60×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 57% chance the next rating action is stable or better
  • Current rating AA- (investment grade)
  • Interest coverage 3.6×
  • ₹9.22 cr of rated limits not yet tied to a lender

Rated limits by facility

Timeline

12 Oct 2026 ICRA reaffirmed: AA- (Stable)Rated limits ₹1,763.36 cr ICRA rationale
12 Oct 2026 New borrowing arranged (term loans)
From the report

The company’s average fund- based working capital utilisation stood at a relatively low level of around 43% during the last 15 months, ended in July 2026, leaving adequate cushion in its sanctioned working capital limits to meet any incremental funding requirements.

ICRA rationale
05 Oct 2026 CARE reaffirmed: AA- (Stable)Rated limits ₹1,754.14 cr CARE rationale
05 Oct 2026 Cash & liquid funds ₹303.64 cr
From the report

Press Release Liquidity: Strong ICIL’s liquidity position remained strong, supported by cash and liquid investments of ₹303.64 crore and gross cash accruals (GCA) of ₹273.07 crore in FY26.

CARE rationale
05 Oct 2026 Average working-capital utilisation 58%
From the report

Average fund-based working-capital utilisation of ~58% and available headroom in non-fund- based limits provide adequate financial flexibility to meet scheduled debt repayments, planned capital expenditure and incremental working-capital requirements.

CARE rationale
05 Sep 2025 CARE reaffirmed: AA- (Stable)Rated limits ₹1,755.79 cr CARE rationale
05 Sep 2025 Cash & liquid funds ₹207 cr
From the report

The company’s interest coverage ratio of 3.5x as on June 30, 2025, along with cash and liquid investments of ₹207 crore (July 2025) and ~70% utilisation of working capital limits, provide adeq uate liquidity cushion to withstand near-term headwinds.

CARE rationale
05 Sep 2025 Average working-capital utilisation 70%
From the report

The average working capital utilisation remained mode rate at 70% in the last 12 months ended July 2025.

CARE rationale
05 Sep 2025 Cash & liquid funds ₹207.51 cr
From the report

Liquidity: Strong Unencumbered cash and liquid investments as on July 31, 2025, stood at ₹207.51 crore (cash and bank balances – ₹25.57 crore and liquid investments – ₹181.94 crore).

CARE rationale
05 Sep 2025 Cash & liquid funds ₹78.6 cr
From the report

In Q1FY26, the company has generated gross cash accrual (GCA) of ₹78.60 crore.

CARE rationale
05 Sep 2025 Average working-capital utilisation 70%
From the report

The company also has some headroom available on its fund-based limits considering average utilisation at ~70% for the last 12 months ended July 2025.

CARE rationale
25 Sep 2024 CARE reaffirmed: AA- (Positive)Rated limits ₹1,641.78 cr CARE rationale
25 Sep 2024 Average working-capital utilisation 66%
From the report

The average working capital utilisation remained moderate at 66% in the last 12 months ended August 2024.

CARE rationale
25 Sep 2024 Cash & liquid funds ₹225.23 cr
From the report

Press Release Liquidity: Strong ICIL has strong liquidity with unencumbered cash and liquid investments of ₹225.23 crore (cash and bank balances – ₹92.55 crore and liquid investments – ₹132.67 crore) as on March 31, 2024.

CARE rationale
25 Sep 2024 Average working-capital utilisation 66%
From the report

The company also has some headroom available on its working capital limits considering average utilisation at ~66% for the last 12 months ended August 2024.

CARE rationale
30 Nov 2023 CARE reaffirmed: AA- (Stable)Rated limits ₹1,675.54 cr CARE rationale
30 Nov 2023 Full repayment of debt
From the report

As on September 30, 2023, the debt coverage metrics have improved primarily on account of accretion of profits and scheduled repayment of debt obligations.

CARE rationale
30 Nov 2023 Average working-capital utilisation 70%
From the report

The average working capital utilisation remained high, at 70% during the last 12 months ended October 31, 2023.

CARE rationale
30 Nov 2023 Average working-capital utilisation 53%
From the report

However, for the month ended October 31, 2023, the average working capital utilization remained moderate at 53%.

CARE rationale
30 Nov 2023 Cash & liquid funds ₹172.52 cr
From the report

Liquidity: Strong ICIL has strong liquidity with cash and liquid investments of ₹172.52 crore as on September 30, 2023, and has generated GCA of ₹235.24 crore in H1FY24.

CARE rationale
30 Nov 2023 Average working-capital utilisation 70%
From the report

The company’s average working capital utilisation remained high, at 70% for the last 12 months ended October 31, 2023.

CARE rationale
22 Dec 2022 CARE reaffirmed: AA- (Stable)Rated limits ₹1,755.51 cr CARE rationale
22 Dec 2022 Average working-capital utilisation 80%
From the report

The average working capital utilisation remained high , at 80% during the last 12 months ended October 31, 2022.

CARE rationale
22 Dec 2022 Cash & liquid funds ₹236.23 cr
From the report

Press Release Liquidity: Strong ICIL has strong liquidity with cash and liquid investments of ₹236.23 crore as on September 30, 2022, and has generated GCA of ₹173.57 crore in H1FY23.

CARE rationale
22 Dec 2022 Average working-capital utilisation 80%
From the report

The company’s average working capital utilisation remained high, at 80% for the last 12 months ended October 31, 2022.

CARE rationale
05 Dec 2022 CARE reaffirmed: AA- (Stable)Rated limits ₹2,296.64 cr CARE rationale
05 Dec 2022 Average working-capital utilisation 80%
From the report

The average working capital utilisation remained high , at 80% during the last 12 months ended October 31, 2022.

CARE rationale
05 Dec 2022 Cash & liquid funds ₹236.23 cr
From the report

Liquidity: Strong ICIL has strong liquidity with cash and liquid investments of ₹236.23 crore as on September 30, 2022, and has generated GCA of ₹173.57 crore in H1FY23.

CARE rationale
05 Dec 2022 Average working-capital utilisation 80%
From the report

The company’s average working capital utilisation remained high, at 80% for the last 12 months ended October 31, 2022.

CARE rationale
15 Dec 2021 CARE other: — CARE rationale
15 Dec 2021 Cash & liquid funds ₹350 cr
From the report

ICIL will be majorly utilizing its internal accruals and existing cash & cash equivalents of Rs 350 crs (as on Sept 2021) along with debt of around Rs 200 crs for funding the acquisition.

CARE rationale
07 Sep 2021 CARE revised: A+ (Positive)Rated limits ₹1,148.32 cr CARE rationale
07 Sep 2021 Maximum working-capital utilisation 68.89%
From the report

Average maximum working capital utilisation remained moderate at 68.89% during last 12 months ended June 2021.

CARE rationale
23 Sep 2020 CARE reaffirmed: A+ (Stable)Rated limits ₹1,609.76 cr CARE rationale
23 Sep 2020 Maximum working-capital utilisation 63.39%
From the report

Average maximum working capital utilisation remained moderate at 63.39% during last 12 months ended July 2020.

CARE rationale
10 Sep 2019 CARE revised: A+ (Stable)Rated limits ₹826.44 cr CARE rationale
10 Sep 2019 Maximum working-capital utilisation 60.58%
From the report

Average maximum working capital utilisation remained moderate at 60.58% during last 12 months ended July 2019.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeOFFICE NO. 1, PLOT NO. 266, VILLAGE ALTE, KUMBHOJ ROAD, TALUKA HATKANANGALE,, KOLHAPUR, IN-MH, 416109
GSTIN—
Email—
Websitehttps://www.indocount.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Indo Count Industries

Competitors10identified
Locations2most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Grasim Industries Textiles, Cotton & Yarn · Apparel, Textiles & Footwear grasim.com 1948 Ujjain, India
Arvind Limited Textiles, Cotton & Yarn · Apparel, Textiles & Footwear arvind.com — Ahmedabad, India
Welspun Living Textiles, Cotton & Yarn · Apparel, Textiles & Footwear welspunliving.com — Anjar, India
Raymond Formal & Premium Menswear · Apparel, Textiles & Footwear raymond.in — Ratnagiri, India
Alok Industries Discovered Companies · Other Industries alokind.com 1986 Silvassa, India
Trident Part of Mondelez International. tridentindia.com — India
Raymond Lifestyle Limited Discovered Companies · Other Industries — — Aurangabad, Maharashtra, India
KPR Mill Textiles, Cotton & Yarn · Apparel, Textiles & Footwear kprmilllimited.com — India
Page Industries Textiles, Cotton & Yarn · Apparel, Textiles & Footwear pageind.com 1995 Bengaluru, India
Nahar Spinning Mills Textiles, Cotton & Yarn · Apparel, Textiles & Footwear owmnahar.com — Ludhiana, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Bed linen

Filings

No filings on record yet.